Article

Targeted metabolomic profiling as a tool for diagnostics of patients with non- small-cell lung cancer

2023-06-01

Abstract excerpt

Lung cancer is referred to as the second most common cancer worldwide and is mainly associated with poor diagnostics and the absence of personalized therapy. Metabolomics may provide significant insights into the improvement of lung cancer diagnostics and treatment through identification of the specific biomarkers or biomarker panels that characterize the pathological state of the patient. We performed targeted me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c21da68c-af37-599b-ae15-1310f3c7dc20
DOI: 10.21203/rs.3.rs-2948248/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeted metabolomic profiling as a tool for diagnostics of patients with non- small-cell lung cancerDOI 10.21203/rs.3.rs-2948248/v1Read

Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancerSemantic proximity Read

A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients.Semantic proximity Read

Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.Semantic proximity Read

Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.Semantic proximity Read

Data Driven Identification of Plasma Metabolite Clusters and Metabolites of Interest for Potential Detection of Early Stage Non-Small Cell Lung Cancer Cases Versus Cancer-Free ControlsSemantic proximity Read

Metabolomic profiling reveals distinct metabolic patterns and a potential circulating biomarker in pre-COPDSemantic proximity Read

Multi-omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinomaSemantic proximity Read

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-stage Lung Cancer DiagnosisSemantic proximity Read

Advancing Non-Small-Cell Lung Cancer Management Through Multi-Omics Integration: Insights from Genomics, Metabolomics, and RadiomicsSemantic proximity Read

Histological and genetic features and therapeutic responses of lung cancers explored via the global analysis of their metabolome profile.Semantic proximity Read

Probing Folate-Responsive and Stage-Sensitive Metabolomics and Transcriptional Co-Expression Network Markers to Predict Prognosis of Non-Small Cell Lung Cancer PatientsSemantic proximity Read

Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment.Semantic proximity Read